(Q24605776)

English

Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

scientific article

In more languages

Statements

scholarly article

0 references

Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin (English)

0 references

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

15

object named as

Corey J Langer

author given names

Corey J

author last names

Langer

1 reference

20 October 2023

author name string

Daniel D Karp

1

author given names

Daniel D

author last names

Karp

1 reference

20 October 2023

Michael N Pollak

2

author given names

Michael N

author last names

Pollak

1 reference

20 October 2023

Roger B Cohen

3

author given names

Roger B

author last names

Cohen

1 reference

20 October 2023

Peter D Eisenberg

4

author given names

Peter D

author last names

Eisenberg

1 reference

20 October 2023

Paul Haluska

5

author given names

Paul

author last names

Haluska

1 reference

20 October 2023

Donghua Yin

6

author given names

Donghua

author last names

Yin

1 reference

20 October 2023

Allan Lipton

7

author given names

Allan

author last names

Lipton

1 reference

20 October 2023

Laurence Demers

8

author given names

Laurence

author last names

Demers

1 reference

20 October 2023

Kim Leitzel

9

author given names

Kim

author last names

Leitzel

1 reference

20 October 2023

Mary L Hixon

10

author given names

Mary L

author last names

Hixon

1 reference

20 October 2023

Leon W Terstappen

11

author given names

Leon W

author last names

Terstappen

1 reference

20 October 2023

Linda Garland

12

author given names

Linda

author last names

Garland

1 reference

20 October 2023

Luis G Paz-Ares

13

author given names

Luis G

author last names

Paz-Ares

1 reference

20 October 2023

Felipe Cardenal

14

author given names

Felipe

author last names

Cardenal

1 reference

20 October 2023

Antonio Gualberto

16

author given names

Antonio

author last names

Gualberto

1 reference

20 October 2023

language of work or name

0 references

publication date

November 2009

0 references

Journal of Thoracic Oncology

0 references

4

0 references

11

0 references

1397-403

0 references

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

7 April 2017

Detection of mutations in EGFR in circulating lung-cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

7 April 2017

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

7 April 2017

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

26 May 2017

IGF-1 receptor inhibitors in clinical trials--early lessons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

27 September 2017

Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

27 September 2017

Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

27 September 2017

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

28 November 2018

Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

28 November 2018

Development of monoclonal antibodies for the treatment of colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

28 November 2018

Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

28 November 2018

Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

28 November 2018

The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

28 November 2018

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

28 November 2018

Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941876

28 November 2018

Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19745765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/JTO.0B013E3181BA2F1D

0 references

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24605776&oldid=1994113584"